Browse the preliminary programme and build a personalised schedule for the congress.

Displaying One Session

Clinical Focus Session
EBIR
Yes
Date
Mon, Apr 8, 2019
Time
17:00 - 18:30
Location:
Main Auditorium

501.1 - Prognostic factors in metastatic cancer (not TNM)

EBIR
Yes
Session Name
Learning Objectives:
1. To know the importance of tumor location (right-left), biologic and immune scoring in liver cancer
2. To explain if these prognostic factors are for OS or treatment selection
3. To explain how these prognosis factors influence survival

501.2 - Treatment strategies according to the ESMO guidelines

EBIR
Yes
Session Name
Learning Objectives:
1. To describe the recent ESMO guidelines
2. To explain what has changed in the recent guidelines and why
3. To explain the concept of a tool box for interventional treatment and how to use it

501.3 - Immunotherapy in metastatic colorectal cancer: when and how

Session Name
Learning Objectives:
1. To explain the recent development of immunotherapy in CRC liver mets
2. To describe to which patient it may apply ( MSE MSI)
3. To explore the future directions of immunotherapy in this field from the ongoing trials and research

501.4 - Summary of "Ablation of colorectal liver metastases: interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival"

501.5 - Local treatment in oligometastatic disease

EBIR
Yes
Session Name
Learning Objectives:
1. To explain the role of ablation in CRC
2. To compare the surgical to ablation literature with an emphasis on liver sparing surgery results (R1 rate)
3. To describe the best candidates for ablation

501.6 - Intra-arterial therapies in liver-dominant disease

EBIR
Yes
Session Name
Learning Objectives:
1. To describe the different intra-arterial options (intra-arterial chemo, TACE and SIRT)
2. To give the recent results of these techniques
3. To describe the situations where these situations can be proposed and how to choose between them